Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
70%
OVERLAP
BY WEIGHT
59
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
55%
ALSO IN FHLC
FHLC
341
HOLDINGS
19%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus FHLC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 12.5% | 10.2% |
|
JOHNSON & JOHNSON | 7.1% | 8.8% | 7.1% |
|
ABBVIE INC | 4.7% | 5.9% | 4.7% |
|
UNITEDHEALTH GROUP INC | 4.5% | 5.4% | 4.5% |
|
MERCK & CO. INC. | 3.8% | 4.5% | 3.8% |
IXJ Overweight Relative to FHLC
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.7% |
 |
NOVO NORDISK A/S-B | 2.0% |
|
GSK PLC | 1.4% |
 |
SANOFI-AVENTIS | 1.3% |
|
ESSILOR INTERNATIONAL | 0.8% |
 |
HOYA CORP | 0.8% |
|
TAKEDA PHARMACEUTICAL CO LTD | 0.7% |
 |
ARGEN-X SE | 0.7% |
|
LONZA GROUP AG-REG | 0.6% |
IXJ Underweight Relative to FHLC
|
ELI LILLY & CO | -2.3% |
|
JOHNSON & JOHNSON | -1.7% |
|
ABBVIE INC | -1.2% |
|
UNITEDHEALTH GROUP INC | -0.9% |
|
MERCK & CO. INC. | -0.7% |
|
ALNYLAM PHARMACEUTICALS INC | -0.6% |
|
ABBOTT LABORATORIES | -0.5% |
|
AMGEN INC | -0.5% |
|
INSMED INC | -0.5% |
|
NATERA INC | -0.4% |